CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 322 enrolled
Drug / intervention
Innovations in Dementia Empowerment and Action (IDEA) +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03550131
NCT03550131N/ACompleted

Aging With Pride: Innovations in Dementia Empowerment and Action

University of Washington·interventional·Posted Jun 8, 2018·Updated Jul 25, 2024

In Brief

A clinical study evaluating Innovations in Dementia Empowerment and Action (IDEA) and Reducing Disabilities in Alzheimer's Disease (RDAD) for Alzheimer Disease and 5 related conditions. Completed, enrolled 322 participants across 1 site.

Detailed Summary

The lack of efficacious research-based interventions for such vulnerable older adults with Alzheimer's disease and related dementias (AD/RD) and their caregivers (CGs) is a significant public health problem. Caregiving of sexual/gender minority older adults with AD/RD is of concern due to social stigma, marginalization, and isolation, which may be barriers to sustaining caregiving. It is necessary and timely to translate evidence-based culturally adaptable interventions for this underserved and stigmatized population. Reducing Disability in Alzheimer's Disease (RDAD) has been evaluated in a randomized controlled trial and has shown to successfully train community-dwelling CR (care receiver)-CG dyads to increase the physical activity and functioning of individuals with AD/RD and their CGs and to teach CGs techniques for managing behavioral symptoms of CRs. RDAD consequently decreases stress of CGs, delays institutionalization of CRs, and increases health related quality of life (HRQOL) of CRs and CGs. Thus, this study will evaluate the effect of the standard RDAD among lesbian, gay, bisexual, and transgender (LGBT) CRs with AD/RD and their CGs, and this study will test a personalized intervention tailored to better respond to distinct risks experienced by CGs and LGBT CRs with AD/RD, addressing unique sexual/gender minority CG risk factors (e.g., identity management, stigma-related adverse or traumatic life events, and lack of social support).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 8, 2018
Enrollment StartDec 5, 2018
Primary CompletionMay 16, 2023
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 8.1 years ago

Interventions

Innovations in Dementia Empowerment and Action (IDEA)behavioral

The IDEA intervention has the same exposure to treatment as the RDAD intervention. The behavioral component of the treatment manual is adapted to incorporate 3 risk factors that are empirically known to affect midlife and older LGBT populations.These include: 1) identity management; 2) stigma-related adverse/traumatic life events; and 3) lack of social support. All other aspects of the treatment are preserved.

Reducing Disabilities in Alzheimer's Disease (RDAD)behavioral

The RDAD intervention includes behavioral management training for caregiver and activities and exercise training for caregiver and care receiver.